Pura Vida Investments’s Gilead Sciences GILD Stock Holding History

Pura Vida Investments’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-50,602	Closed	-$3.27M	–	244
2021 Q1	$3.27M	Buy	+50,602	New	+$3.26M	0.09%	139
2020 Q2	–	Sell	-50,000	Closed	-$3.74M	–	131
2020 Q1	$3.74M	Buy	+50,000	New	+$3.45M	0.44%	50
2019 Q4	–	Sell	-150,000	Closed	-$9.51M	–	110
2019 Q3	$9.51M	Buy	150,000 +50,000	+50%	+$3.27M	1.62%	26
2019 Q2	$6.76M	Hold	100,000	–	–	1.03%	33
2019 Q1	$6.5M	Buy	+100,000	New	+$6.65M	0.92%	31
2017 Q3	–	Sell	-50,000	Closed	-$3.54M	–	85
2017 Q2	$3.54M	Buy	+50,000	New	+$3.33M	1.41%	30
2015 Q1	–	Sell	-22,500	Closed	-$2.12M	–	73
2014 Q4	$2.12M	Buy	+22,500	New	+$2.33M	0.78%	48

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pura Vida Investments's GILD Position: Q2 2021 in Review

Pura Vida Investments sold out of Gilead Sciences (GILD) in Q2 2021, closing a stake of 50,602 shares — an estimated $3.27M sold.

Pura Vida Investments first reported a position in GILD in Q4 2014 and held it in 7 quarters. The position peaked at $9.51M in Q3 2019. 1,545 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

Pura Vida Investments reported no remaining Gilead Sciences position as of Q2 2021 after selling out during the quarter.
Pura Vida Investments sold 50,602 Gilead Sciences shares in Q2 2021, an estimated $3.27M.
Pura Vida Investments first reported a position in Gilead Sciences in Q4 2014 and held it in 7 quarters.
Pura Vida Investments's Gilead Sciences position peaked at $9.51M in Q3 2019.
1,545 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on Pura Vida Investments's 13F filing for Q2 2021, filed 16 Aug 2021.